Inventor · disambiguated record
Peggy A. Scherle
Also filed as: SCHERLE PEGGY · SCHERLE PEGGY A · SCHERLE PEGGY ANN
6 granted patents·6 pending applications·32 citations·filing 2004–2025
79Inventor score
Top patents by PatentIndex Score
12 records- 0193US10675284B2Treatment of B-cell malignancies by a combination JAK and PI3K inhibitorsINCYTE CORP·Filed 2018·Granted Jun 9, 2020·6 cites·15 claims
- 0293US10064866B2Treatment of B-cell malignancies by a combination JAK and PI3K inhibitorsINCYTE CORP·Filed 2015·Granted Sep 4, 2018·16 cites·31 claims
- 0379US7259000B2Polynucleotides encoding chimeric chemokine receptorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Aug 21, 2007·9 cites·6 claims
- 0479US2024091234A1Treatment of b-cell malignancies by a combination jak and pi3k inhibitorsINCYTE CORP·Filed 2023·Application pending·0 cites
- 0567US2025114354A1Combination treatment regimens - smarca2 degrader with pd-1 inhibitorsPRELUDE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0667US2025114353A1Combination Treatment Regimens - SMARCA2 Degrader With GemcitabinePRELUDE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0766US2021093638A1Treatment of b-cell malignancies by a combination jak and pi3k inhibitorsINCYTE CORP·Filed 2020·Application pending·0 cites
- 0862US8088737B2Compositions, methods and kits relating to Her-2 cleavageFRIEDMAN STEVEN M·Filed 2004·Granted Jan 3, 2012·1 cites·12 claims
- 0956US9345677B2Compositions, methods and kits relating to HER-2 cleavageFRIEDMAN STEVEN M·Filed 2011·Granted May 24, 2016·0 cites·15 claims
- 1055US7910108B2Sheddase inhibitors combined with CD30-binding immunotherapeutics for the treatment of CD30 positive diseasesINCYTE CORP·Filed 2007·Granted Mar 22, 2011·0 cites·12 claims
- 1149US2025281473A1CDK Inhibitors And Their Use As PharmaceuticalsPRELUDE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1245US2025276074A1Brm and brg1 targeting antibody-drug conjugates and methods of use thereofPRELUDE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →